Myocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel
暂无分享,去创建一个
Manfred S. Green | D. Mevorach | E. Anis | M. Bromberg | L. Keinan-Boker | R. Dichtiar | T. Hasin | N. Ash | S. alroy-Preis | Yael Hershkovitz | N. Levi | N. Cedar | Lital Goldberg | Ofer Perzon | Barhoum Barhoum | Nur Magadle | Elchanan Parnassa
[1] Manfred S. Green,et al. Myocarditis after BNT162b2 Vaccination in Israeli Adolescents , 2022, The New England journal of medicine.
[2] Manfred S. Green,et al. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel , 2021, The New England journal of medicine.
[3] Y. Kreiss,et al. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months , 2021, The New England journal of medicine.
[4] D. Vézina,et al. Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses , 2021, Cell Host and Microbe.
[5] Hu Shan,et al. Advances in mRNA Vaccines for Infectious Diseases , 2019, Front. Immunol..